CORDIS · 101060346 · HORIZON
NIMSB NOVA Institute for Medical Systems Biology
Coordinator: UNIVERSIDADE NOVA DE LISBOA (PT)
The rise of chronic diseases is shaping health policy priorities worldwide. As the population ages, these conditions affect increasing portions of society and are more difficult to manage, causing suffering in patients and their families for many years. Such increasing prevalence is a threat to the sustainability of healthcare systems. Thus, an increasing focus has been put on disease prevention and awareness, as well as on precision medicine. This project will create a new Centre of Excellence, NOVA Institute for Medical Systems Biology (NIMSB), which will use the most advanced cell analytic…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €15.0M awarded to the consortium. The project runs over approximately 6 years from 2023-09-01 to 2029-08-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from PT
see all →- Smart4Health — Citizen-centred EU-EHR exchange for personalised health826117 · H2020 · €21.8M
- GIMM-CARE — GIMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY101060102 · HORIZON · €15.0M
- MIA-Portugal — Multidisciplinary Institute of Ageing - Portugal857524 · H2020 · €15.0M
- INESCTEC.OCEAN — Centre of Excellence in Ocean Research and Engineering101136903 · HORIZON · €15.0M
- BIOPOLIS — Teaming to Upgrade to Excellence in Environmental Biology, Ecosystem Research and AgroBiodiversity857251 · H2020 · €15.0M
- GeneT — The Gene Therapy CoE at the Center of Portugal101059981 · HORIZON · €14.0M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
- What is the EU contribution?
- The European Commission contributes €15.0M toward a total project budget of €15.0M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2022-ACCESS-01-two-stage.
- Who coordinates the project?
- The project is coordinated by UNIVERSIDADE NOVA DE LISBOA (PT).
- What is the project timeline?
- The project runs from 2023-09-01 to 2029-08-31 — approximately 6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101060346.